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Hypholoma lateritium is an edible macrofungus with a common distribution in Europe, North America, and the Far East. The aim of this 
study was to investigate the potential anti-inflammatory effects of H. lateritium extracts and its isolated steroids: fasciculic acid B (1), 
fasciculol E (2), fasciculol C (3), lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tetraol (4), fasciculol F (5), and demethylincisterol A2 (6). 
Organic (n-hexane, chloroform and 50% methanol) and water extracts of H. lateritium were subjected to in vitro assays to determine pro-
inflammatory protein levels, such as cyclooxygenase-2 (COX-2), cytosolic prostaglandin E2 synthase (cPGES), and antioxidant nuclear 
factor (erythroid-derived 2)-like 2 (Nrf2). Fungal extracts demonstrated significant activities on pro-inflammatory protein levels with minor 
differences among the activities of the fractions of different polarities. Compounds (1-6) proved to exert notable inhibitory properties on 
COX-2 and were capable to stimulate the Nrf2 pathway. Fungal extracts and compounds (1-6) exerted no cytotoxic activities on RAW 264.7 
cells.  
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Introduction 
The genus Hypholoma, which means “mushrooms with threads”, belongs to the family Strophariaceae, and includes mushroom 
species possessing characteristic well-pigmented pileus and variably developed thread-like veil, which does not form a membranous 
annulus on the stipe.[1] The genus consists of about 30 species worldwide, occurring in temperate to tropical regions, growing on 
decomposing wood, living trees, or soil.[2] Hypholoma species are recognized as active wood and litter decomposers, and play a significant 
role in forest ecosystems, being used not only in bioconversion of cellulose, fabric and dye industrial residues,[3], [4] but also in biological 
control of phytopathogenic fungi.[5], [6] Hypholoma fasciculare is the most widespread and investigated member of the genus, which is 
known for its antioxidant and antimicrobial activities,[7] producing different types of fungal metabolites, e.g. styrylpyrone-type 
compounds (hypholomins, fasciculins),[8] steroids (fasciculic acids, fasciculols)[9], [10] and sesquiterpenoids (fascicularones).[11], [12] 
Apart from H. fasciculare there is H. lateritium (brick cap mushroom), a less known related species, but still with a quite common 
distribution in Europe, North-America and the Far East. It is a saprobic macrofungus, occurring regularly in small tufts or sometimes singly 
on hardwood stumps, and exposed roots of dead hardwood trees.  H. lateritium was reported to contain steroid compounds e.g. 
fasciculols, fasciculic acids and sublateriols[13],[14] as well as sesquiterpenes, e.g. naematolin, a caryophyllane derivative with 
antiproliferative property[15]. We have recently explored the chemistry of this species and identified a series of steroids with remarkable 
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structural diversity including ergostane and lanostane derivatives, along with highly degraded sterols with ion channel modulating 
properties.[16],[17] 
As regard the pharmacology of H. lateritium, previous investigations revealed that this species possesses considerable biological 
properties; however, these experiments were performed with crude extracts without identifying the major fungal metabolites responsible 
for the observed biological activity. In their study, Lee at al. demonstrated that the extract of this species decreases TNF-α-induced 
inflammation in human umbilical vein endothelial cells. The n-butanol fraction of H. lateritium inhibited TNF-α-induced monocyte 
adhesion to endothelial cells; moreover, it dose-dependently decreased the expression of inducible nitrogen oxygen synthase and 
cyclooxygenase-2.[18] In another paper Lee et al. investigated the inhibitory effect of H. lateritium extract on highly invasive and metastatic 
tumor cells. The n-hexane fraction of brick cap significantly inhibited the invasion and migration of MDA-MB-231 breast cancer cells in the 
Matrigel invasion assay and wound-healing investigations, respectively. The results obtained suggested that n-hexane extract of H. 
lateritium inhibits the metastatic potential of MDA-MB-231 cells by inhibiting the phosphorylation of JNK/p38 and reducing AP-1 and NF-
κB DNA-binding activities.[19] 
Despite of its wide geographical distribution and richness in various fungal metabolites with pharmacological potential, the 
ethnomycological profile of H. lateritium is rather unexplored. Nonetheless this mushroom was used in Swedish folk medicine as an anti-
inflammatory agent in alleviating symptoms of rheumatic disorder.[20] Therefore, we conducted a research to explore the anti-
inflammatory properties of H. lateritium extracts and its characteristic constituents, fasciculic acid B (1), fasciculol E (2), fasciculol C (3), 
lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tetraol (4), fasciculol F (5), and demethylincisterol A2 (6) for the purpose of confirming 
the traditional use of this species. 
Results and Discussion 
Basidiomycota mushrooms are known to possess various beneficial pharmacological properties including anti-inflammatory 
activity.[21] Previous studies revealed that several extracts prepared from certain edible mushrooms have anti-inflammatory potential: 
Cantharellus cibarius,[22] Imleria badia,[23] and Agaricus bisporus.[24] In the current study, we examined the pro- or anti-inflammatory 
properties of H. lateritium extracts and identified specific fungal metabolites (1-6) which may contribute to the favorable biological 
activities of this fungal species. Accordingly, organic (n-hexane, chloroform and 50% methanol) and H2O extracts of H. lateritium were 
prepared, then they were subjected to in vitro tests in order to determine the pro-inflammatory protein levels, such as COX-2, cPGES as 
well as Nrf2 using Western blot techniques. Regarding the cytotoxic effect, no such activities were observed in RAW 264.7 cells incubated 
with mushroom extracts and fungal metabolites 1-6. Cell viabilities were around 100% after treatment. According to results, all fractions 
demonstrated significant biological activities in the assays performed, however, minor differences were observed among the activities of 
the fractions with different polarities (Fig. 1). 
In RAW 264.7 cells activated with LPS and incubated with mushroom extracts A-D an increase of Nrf2 was observed. In the same way, 
higher levels of cPGES protein were detected in macrophages co-treated with LPS and extracts A-D, but the values obtained were 
significantly lower compared to those of the LPS-activated cells. The investigations revealed a decrease in COX-2-levels in RAW 264.7 
cells co-treated with mushrooms extracts and LPS in comparison with the experiment of LPS-activated macrophages. 
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Figure 1. Levels of COX-2 (a), cPGES (b) and Nrf2 (c) and their representative blots (d) in RAW 264.7 cells incubated with extracts of H. lateritium (100 µg) and 
activated with LPS. N=5. # vs control, * vs LPS, p<0.05. 
To identify the main constituents of H. lateritium responsible for the detected anti-inflammatory properties of the crude fungal extracts 
we proposed to perform the pharmacological assay of characteristic compounds of H. lateritium. The fungal metabolites investigated in 
the current study belong to the vast class of steroids (Fig. 2). 
  
Figure 2. Steroids from Hypholoma lateritium 
Fasciculic acid B (1), fasciculol E (2), fasciculol C (3), and fasciculol F (5) represent a special group of compounds known as fasciculols which 
are specific to mushrooms of the Hypholoma genus, especially H. fasciculare and H. lateritium, lanosta-7,9(11)-diene-12β,21α-epoxy-
2α,3β,24β,25-tetraol (4) is a related steroid recently identified in H. lateritium, while demethylincisterol A2 (6) is a highly degraded sterol 
reported originally from a marine sponge of Homaxinella sp.[25] Previous investigations revealed that these compounds could have 
important pharmacological properties, including the calmodulin antagonistic activity of fasciculic acid B (1) and the cytotoxic property of 
demethylincisterol A2 (6).[10],[25] Our experiments (Fig. 3) revealed that 1-6 activated cPGES, but levels of this protein were lower than 
those in LPS-activated RAW 264.7 cells. In cells activated with LPS and incubated with 1-6 we experienced an increase of Nrf2. 
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Compounds 1-6 in general proved to possess similar activities; however, fasciculol C (3) represents a particular case, because when cells 
were treated with 3 alone the amount of cPGES was the lowest, while the level of Nrf2 was the highest among the values obtained in all 
experiments. 
 
Figure 3. Levels of COX-2 (a), cPGES (b) and Nrf2 (c) and their representative blots (d) in RAW 264.7 cells incubated with compounds 1-6 
isolated from H. lateritium (10 µg) and activated with LPS. N=5. # vs control, * vs LPS, p<0.05. 
 
Macrophages activated with LPS and incubated with fungal metabolites were characterized by decreased COX-2 levels when 
compared to LPS-activated macrophages.  
Nrf2, or nuclear factor (erythroid-derived 2)-like 2, is an essential transcription factor that controls the expression of antioxidant 
proteins that protect against oxidative damage produced by injury and inflammation. It is a key participant of cellular defense mechanism; 
activation of Nrf2 leads to a subsequent production of proteins and antioxidant enzymes, providing the damaged cells and tissues with a 
complex antioxidant defense. Plenty of studies unequivocally demonstrate that many plant metabolites from fruits and vegetables, e.g. 
curcumin,[26] resveratrol[27] and sulforaphane[28] are capable of regulating Nrf2., Although many plants produce a variety of compounds 
with Nrf2 activity, the potential of mushroom metabolites in this view is largely unexplored. However, extracts from Agaricus bisporus 
mycelia enriched in α-linolenic acid presented Nrf2 modulating activity.[24] Only a few fungal compounds are known to regulate the Nrf2 
pathway, including the benzoid type antrolone and the ubiquinone derivative antroquinonol identified in Antrodia sp., and several steroids 
from the renowned Ganoderma lucidum .[29],[30] 
The current study demonstrates that the examined fungal steroids could have several beneficial pharmacological properties providing 
multiple opportunities for the potential therapeutic application of these secondary metabolites.  
 
 
Conclusions 
Organic and water extracts of H. lateritium and compounds 1-6 proved to demonstrate not only considerable inhibitory properties on 
COX-2, but they are also capable to stimulate the Nrf2 pathway. Our results provide experimental evidence that extracts of Hypholoma 
lateritium, and characteristic compounds of the n-hexane (6), chloroform (1–5) and more polar (1, 3) fractions possess anti-inflammatory 
activities which warrants to be explored in further pharmacological studies. 
Experimental Section 
Mushroom material 
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Sporocarps of Hypholoma lateritium (Schaeff.) P. Kumm (Strophariaceae family) were gathered in September 2015 in the vicinity of 
Bakonybél, Hungary. Fungal identification was made by Attila Sándor (Hungarian Mycological Society). A voucher specimen (No. H018) 
has been deposited at the Department of Pharmacognosy, University of Szeged, Szeged, Hungary. 
Sample preparation 
Sporocarps of H. lateritium were lyophilized and ground with a grinder, then a 10 g sample was extracted with 3 × 100 mL methanol for 3 × 
15 min using ultrasonic bath. Following filtration, the extracts were combined and concentrated in vacuum. The residue was dissolved in 
50 mL of 50% aqueous MeOH and was subjected to liquid–liquid partition between n-hexane (4 × 25 mL) (extract A) and CHCl3 (4 × 25 mL) 
(extract B) and the remaining material provided extract C. After extraction with MeOH, the residual fungal material was dried and 
extracted with 50 mL of boiling H2O for 15 min. The filtered extract was lyophilized, giving extract D. 
Isolation, identification and characterization of fasciculic acid B (1), fasciculol E (2), fasciculol C (3), lanosta-7,9(11)-diene-12β,21α-
epoxy-2α,3β,24β,25-tetraol (4), fasciculol F (5), and demethylincisterol A2 (6) have been previously performed by our research group and 
are described in a publication by Chuluunbaatar et al.[16] 
 
 Cell cultures 
Murine macrophages RAW 264.7 (TIB-71, ATCC, Manassas, VA, USA) were cultured in Dulbecco's Modified Eagle's Medium 
supplemented with 10% Fetal Bovine Serum (FBS) and 1% solution of antibiotics (100 IU/mL penicillin, 0.1 µg/mL streptomycin). Cells 
were maintained at 37 °C in humidified atmosphere of 5% CO2 in air and were finally seeded into a 6-well plate (Sarstedt AG&Co., 
Nümbrecht, Germany) at a density of 5 × 105 cells/well in 2 mL of medium. Cell morphology was investigated in every step of the 
procedure by an inverted light microscope (Olympus, Tokyo, Japan). Cell viability during culturing was assessed with a Trypan Blue 
(Thermo Fisher Scientific, Waltham, MA, USA) exclusion test. RAW 264.7 cells were activated with LPS (10 ng/mL; Sigma–Aldrich, Saint 
Louis, MO, USA) and incubated overnight. After that macrophages were treated with mushroom extracts A-D of H. lateritium at 
concentrations of 50 and 100 µg for 24 h or with the isolated compounds 1-6 (1 and 10 µg) for 24 h. Following 24 h of incubation, the cells 
after scrapping were collected.  
 
Cell proliferation XTT assay 
Cell proliferation was evaluated using a sodium 2,3,-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)-carbonyl]-2H-
tetrazolium) inner salt (XTT) with N-methyl-dibenzopyrazine methyl sulfate) working as the intermediate electron carrier (PMS). RAW 
264.7 cells were seeded in 96-well plates (2.5 × 103 cells/well) and incubated for 24 h. The medium was then removed and 0.5; 1; 2.5; 5; 10; 
50 and 100 µg of mushroom extracts A-D as well as compounds 1-6 were added to FCS-free medium and incubated for the next 24 h. 
Then XTT solution (50 μL) was added to each well and incubated for 4 h at 37 °C according to the manufacturer instruction (Sigma-
Aldrich). The absorbance was measured at 475 nm and 630 nm in Omega plate reader (BMG LABTECH, San Diego, CA, USA). The specific 
absorbance of the sample was calculated as follows: Specific Absorbance = A475nm (sample) ‒ A475nm (blank) ‒ A660nm (sample). Cell viability 
was expressed as the percentage of control.  
 
Western blot for quantity of COX-2, cPGES and Nrf2 receptor  
M-PER mammalian protein extraction reagent (Thermo Scientific, Rockford, IL, USA) with protease inhibitor cocktail set III (Merck, 
Darmstadt, Germany) was used for cell lysates preparation. Total protein concentrations were quantified using the Bradford reaction. 
Forty µg of proteins per sample were solubilized in a Laemmli buffer with 2% mercaptoethanol (BioRad, Hercules, CA, USA) and subjected 
to 10% SDS-polyacrylamide gel electrophoresis. Primary antibodies were used: anti-cyclooxygenase-2 (COX-2), anti-β-actin diluted 
1:1000 (Thermo Fisher Scientific), anti-prostaglandin E2 synthase (Cayman Chemical, Ann Arbor, MI, USA) diluted 1:1000, anti-Nrf2 
receptor (GeneTex, Irvine, CA, USA) diluted 1:200 and secondary antibody anti rabbit IgG (HRP) (Thermo Fisher Scientific, 1:2000). 
Proteins were determined using the Western blotting detection kit Clarity Western ECL Luminol Substrate (Bio-Rad, USA). The integrated 
optical densities of the bands were measured using Chemi Doc Camera with Image Lab software (BioRad). 
 
Statistical analysis 
All the results are presented as means ± standard deviation (SD). The statistical analysis was carried out using the one-way ANOVA; p < 
0.05 was considered significant. 
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